🔗 Visit the ClinicalTrials.gov page for NCT00855218
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Hepatocellular carcinoma: A global view. | Nat Rev Gastroenterol Hepatol | 2010 | 5.87 |
| 2 | Trial watch: Chemotherapy with immunogenic cell death inducers. | Oncoimmunology | 2012 | 1.33 |
| 3 | Design and rationale for the non-interventional Global Investigation of Therapeutic DEcisions in Hepatocellular Carcinoma and Of its Treatment with Sorafenib (GIDEON) study. | Int J Clin Pract | 2010 | 1.31 |
| 4 | Sorafenib or placebo plus TACE with doxorubicin-eluting beads for intermediate stage HCC: The SPACE trial. | J Hepatol | 2016 | 1.24 |
| 5 | Transarterial chemoembolization (TACE) plus sorafenib versus TACE for intermediate or advanced stage hepatocellular carcinoma: a meta-analysis. | PLoS One | 2014 | 0.98 |
| 6 | Eastern Asian expert panel opinion: designing clinical trials of molecular targeted therapy for hepatocellular carcinoma. | BMC Cancer | 2010 | 0.79 |
| 7 | Systemic therapy in hepatocellular carcinoma. | Clin Liver Dis | 2011 | 0.78 |